Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05417568

Oxalate-Driven Host Responses in Kidney Stone Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study is looking to understand the role of oxalate on kidney stone development and immunity. This study will enroll healthy participants and participants with calcium oxalate kidney stones (CaOx KS). Participants will be in this study for about 3 weeks, consume controlled diets, and provide blood and urine specimens.

Detailed description

The purpose of this longitudinal study is to examine the effects of dietary oxalate on nanocrystalluria and the immune system. Oxalate is a small molecule found in plants and plant-derived food. It has been shown that meals containing high amounts of oxalate can increase urinary oxalate excretion, which is a risk factor for calcium oxalate kidney stones (CaOx KS). Small increases in oxalate can stimulate urinary crystals to form which can elicit an immune response. This study consists of having healthy subjects and patients with CaOx KS consume both low and oxalate enriched diets to evaluate the effect of oxalate on urinary crystals and immune responses. Participants will receive a low or high oxalate diet for 4 days prior to having a wash-out period for 6 days. Participants will then crossover to the opposite oxalate diet for four more days.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow Oxalate DietParticipants will consume a diet that is controlled in its daily contents of oxalate and calcium, and in its content of carbohydrate, fat, and protein. Participants will be asked not to take any dietary supplements, exercise strenuously, or consume food or drink that is not provided to them.
DIETARY_SUPPLEMENTHigh Oxalate DietParticipants will consume a diet that is controlled in its daily contents of oxalate and calcium, and in its content of carbohydrate, fat, and protein. Participants will be asked not to take any dietary supplements, exercise strenuously, or consume food or drink that is not provided to them.

Timeline

Start date
2023-05-19
Primary completion
2027-05-30
Completion
2027-05-30
First posted
2022-06-14
Last updated
2025-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05417568. Inclusion in this directory is not an endorsement.